RedHill Biopharma reported $356K in Debt for its fiscal quarter ending in December of 2024.


Debt Change Date
Clal Biotechnology ILS 35.76M 28.27M Dec/2023
Compugen USD 2.97M 58K Jun/2025
Cronos Group USD 2.01M 2.01M Jun/2025
RedHill Biopharma USD 356K 202K Dec/2024